1. Interventions for treating acute high altitude illness
2. Lee, E., Yim, S., Lee, S.K. and Park, H. (2002) Two Transactivation Domains of Hypoxia-Inducible Factor-1alpha Regulated by the MEK-1/p42/p44 MAPK Pathway. Mole-cules and Cells, 14, 9-15.
3. Differences in Tolerance to Hypoxia: Physiological, Biochemical, and Molecular-Biological Characteristics
4. Physiological Risk Factors for Severe High-Altitude Illness
5. Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate